Inhaltsverzeichnis
Werbung
Literaturliste
Literaturliste
Ahmadi, M, and Q Q Rodrigo. 2013. "Automatic denoising of single-trial evoked potentials."
NeuroImage:672-680.
Audo, I., M. Michaelides, A. G. Robson, M. Hawlina, V. Vaclavik, J. M. Sandbach, M. M.
Neveu, C. R. Hogg, D. M. Hunt, A. T. Moore, A. C. Bird, A. R. Webster, and G. E.
Holder. 2008. "Phenotypic variation in enhanced S-cone syndrome."
Ophthalmol Vis Sci 49 (5):2082-93. doi: 10.1167/iovs.05-1629.
Berson, EL. 1993. "Retinitis pigmentosa: The Friedenwald Lecture."
Ophthalmology and Visual Science 34:1659-1673.
Brigell, M. G., B. Chiang, A. Y. Maa, and C. Q. Davis. 2020. "Enhancing Risk Assessment in
Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and
Structure." Transl Vis Sci Technol 9 (9):40. doi: 10.1167/tvst.9.9.40.
Centers for Disease Control and Prevention. 2011. National Diabetes Fact Sheet, 2011. edited
by US Department of Health and Human Services, Centers for Disease Control and
Prevention.
Cideciyan, A, and S Jacobson. 1996. "An alternative phototransduction model for human rod
and cone ERG a-waves: normal parameters and variation with age." Vision Res:2609-
21.
Cideciyan, A. V., and S. G. Jacobson. 1993. "Negative electroretinograms in retinitis
pigmentosa." Invest Ophthalmol Vis Sci 34 (12):3253-63.
CLSI. 2008. Guideline for Defining, Establishing, and Verifying Reference Intervals in the
Clinical Laboratory; Approved Guideline—Third Edition. CLSI Document EP28-A3c.
Wayne, PA: Clinical and Laboratory Standards Institute.
Davis, C. Q., O. Kraszewska, and C. Manning. 2017. "Constant luminance (cd.s/m2) versus
constant retinal illuminance (Td.s) stimulation in flicker ERGs." Doc Ophthalmol. doi:
10.1007/s10633-017-9572-3.
Davis, M. D., M. R. Fisher, R. E. Gangnon, F. Barton, L. M. Aiello, E. Y. Chew, F. L. Ferris,
3rd, and G. L. Knatterud. 1998. "Risk factors for high-risk proliferative diabetic
retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report
#18." Invest Ophthalmol Vis Sci 39 (2):233-52.
Degirmenci, M. F. K., S. Demirel, F. Batioglu, and E. Ozmert. 2018. "Role of a mydriasis-free,
full-field flicker ERG device in the detection of diabetic retinopathy." Doc Ophthalmol
137 (3):131-141. doi: 10.1007/s10633-018-9656-8.
FDA Advisory Committee. 2009. Sabril® (vigabatrin) for Oral Solution for Infantile Spasms.
Fishman, G A, D G Birch, G E Holder, and M G Brigell. 2001. Electrophysiologic Testing:
The Foundation of the American Academy of Ophthalmology.
Fukuo, M., M. Kondo, A. Hirose, H. Fukushima, K. Ikesugi, M. Sugimoto, K. Kato, Y.
Uchigata, and S. Kitano. 2016. "Screening for diabetic retinopathy using new
mydriasis-free, full-field flicker ERG recording device."
10.1038/srep36591.
Gouras, P., C. J. MacKay, and S. Yamamoto. 1993. "The human S-cone electroretinogram and
its variation among subjects with and without L and M-cone function."
Ophthalmol Vis Sci 34 (8):2437-42.
Grace, S. F., B. L. Lam, W. J. Feuer, C. J. Osigian, K. M. Cavuoto, and H. Capo. 2017.
"Nonsedated handheld electroretinogram as a screening test of retinal dysfunction in
pediatric patients with nystagmus." J AAPOS. doi: 10.1016/j.jaapos.2017.06.022.
Heckenlively, JR, and GB Arden. 2006. Principles and Practice of Clinical Electrophysiology
of Vision. Cambridge, MA: MIT Press.
RETeval
Benutzerhandbuch
Invest
Investigative
Sci Rep 6:36591. doi:
Invest
79
Werbung
Inhaltsverzeichnis
